Notably, several point and truncation mutations have been identified in human cancers in the DNA binding region of BRG1 and hBRM BRDs (see Supplementary Fig. 15) indicating that this activity is important for the function of BRG1/hBRM and may contribute to tumour suppression39. This evidence concerns the gene SMARCA2 and neoplasm.